Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.

Most models to predict biochemical recurrence (BCR) of prostate cancer use pretreatment serum prostate-specific antigen (PSA), clinical stage and prostate biopsy Gleason grade. We investigated whether human glandular kallikrein 2 (hK2) and free prostate-specific antigen (fPSA) measured in pretreatme...

Full description

Bibliographic Details
Main Authors: Steuber, T, Vickers, A, Haese, A, Becker, C, Pettersson, K, Chun, F, Kattan, M, Eastham, J, Scardino, P, Huland, H, Lilja, H
Format: Journal article
Language:English
Published: 2006